SI3150227T1 - Anorganski nanodelci z visoko gostoto za uničenje celic in-vivo - Google Patents

Anorganski nanodelci z visoko gostoto za uničenje celic in-vivo

Info

Publication number
SI3150227T1
SI3150227T1 SI200931905T SI200931905T SI3150227T1 SI 3150227 T1 SI3150227 T1 SI 3150227T1 SI 200931905 T SI200931905 T SI 200931905T SI 200931905 T SI200931905 T SI 200931905T SI 3150227 T1 SI3150227 T1 SI 3150227T1
Authority
SI
Slovenia
Prior art keywords
vivo
high density
inorganic nanoparticles
destroy cells
destroy
Prior art date
Application number
SI200931905T
Other languages
English (en)
Inventor
Laurent Levy
Agnes Pottier
Annabelle Rouet
Julie Marill
Corinne Devaux
Matthieu Germain
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of SI3150227T1 publication Critical patent/SI3150227T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/244Lanthanides; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
SI200931905T 2008-06-05 2009-06-04 Anorganski nanodelci z visoko gostoto za uničenje celic in-vivo SI3150227T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08157686A EP2130553A1 (en) 2008-06-05 2008-06-05 Inorganic nanoparticles of high density to destroy cells in-vivo
US6020208P 2008-06-10 2008-06-10
EP16187263.5A EP3150227B1 (en) 2008-06-05 2009-06-04 Inorganic nanoparticles of high density to destroy cells in-vivo

Publications (1)

Publication Number Publication Date
SI3150227T1 true SI3150227T1 (sl) 2019-02-28

Family

ID=39734334

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200931905T SI3150227T1 (sl) 2008-06-05 2009-06-04 Anorganski nanodelci z visoko gostoto za uničenje celic in-vivo
SI200931555A SI2300054T1 (sl) 2008-06-05 2009-06-04 Anorganski nanodelci z visoko gostoto za uničenje celic in-vivo

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200931555A SI2300054T1 (sl) 2008-06-05 2009-06-04 Anorganski nanodelci z visoko gostoto za uničenje celic in-vivo

Country Status (26)

Country Link
US (1) US8845507B2 (sl)
EP (4) EP2130553A1 (sl)
JP (1) JP5734181B2 (sl)
KR (1) KR101639281B1 (sl)
CN (1) CN102056628B (sl)
AU (1) AU2009254550B2 (sl)
BR (1) BRPI0913410B1 (sl)
CA (1) CA2727576C (sl)
CY (2) CY1118217T1 (sl)
DK (2) DK2300054T3 (sl)
EA (1) EA023012B1 (sl)
ES (2) ES2702249T3 (sl)
HR (2) HRP20161465T8 (sl)
HU (2) HUE040247T2 (sl)
IL (1) IL209625A (sl)
LT (2) LT2300054T (sl)
MA (1) MA32453B1 (sl)
MX (1) MX2010013322A (sl)
NZ (1) NZ589888A (sl)
PL (2) PL2300054T3 (sl)
PT (2) PT3150227T (sl)
SG (1) SG10201405288WA (sl)
SI (2) SI3150227T1 (sl)
TR (1) TR201819077T4 (sl)
WO (1) WO2009147214A2 (sl)
ZA (1) ZA201100082B (sl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004075975A2 (en) * 2003-02-24 2004-09-10 Pomper Mark E Mobile radiation treatment vehicle and method
US8657354B2 (en) 2006-05-19 2014-02-25 Breya, Llc. Mobile radiation therapy
US8459714B2 (en) 2006-05-19 2013-06-11 Breya, Llc. Mobile radiation therapy
US8728440B2 (en) 2012-08-23 2014-05-20 General Electric Company Nanoparticulate compositions for diagnostic imaging
US9399075B2 (en) 2008-12-29 2016-07-26 General Electric Company Nanoparticle contrast agents for diagnostic imaging
EP2275137A1 (en) 2009-07-10 2011-01-19 Nanobiotix Metallic nanoparticles, preparation and uses thereof
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
EP2499677B1 (en) * 2009-11-10 2022-03-30 Immunolight, LLC Up coversion system for production of light for treatment of a cell proliferation related disorder
EP2560916B1 (en) * 2010-04-23 2020-06-03 Pixelligent Technologies, LLC Synthesis, capping of a dispersion of nanocrystals
CN107416764A (zh) 2010-10-27 2017-12-01 皮瑟莱根特科技有限责任公司 纳米晶体的合成、盖帽和分散
US9359689B2 (en) 2011-10-26 2016-06-07 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
US10945965B2 (en) 2011-12-16 2021-03-16 Nanobiotix Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
EP2877212A4 (en) * 2012-06-14 2016-04-27 Univ Arkansas COMPOSITIONS AND METHODS FOR NON-INVASIVE DETECTION AND TREATMENT OF IN VIVO HYPOXIC CELLS
US8821838B2 (en) 2012-08-23 2014-09-02 General Electric Company Nanoparticulate compositions for diagnostic imaging
PL2948179T3 (pl) * 2013-01-25 2019-10-31 Nanobiotix Kompozycje zawierające nanocząstki tlenku hafnu(iv) lub tlenku renu(iv) w połączeniu z promieniowaniem jonizującym do leczenia nowotworu
US9095616B2 (en) * 2013-02-19 2015-08-04 National Health Research Institutes Caged platinum nanoclusters for anticancer chemotherapeutics
US10413509B2 (en) 2013-05-30 2019-09-17 Nanobiotix Pharmaceutical composition, preparation and uses thereof
KR20160027009A (ko) 2013-06-20 2016-03-09 나노비오띡스 의학적 진단에 사용되는 조성물 및 방법
EP2886128A1 (en) * 2013-12-20 2015-06-24 Nanobiotix Pharmaceutical composition comprising nanoparticles, preparation and uses thereof
WO2016083331A1 (en) 2014-11-25 2016-06-02 Nanobiotix Pharmaceutical composition, preparation and uses thereof
AR102782A1 (es) 2014-11-25 2017-03-22 Nanobiotix Composición farmacéutica, su preparación y sus usos
AR102781A1 (es) 2014-11-25 2017-03-22 Nanobiotix Composición farmacéutica que combina al menos dos nanopartículas distintas y un compuesto farmacéutico, su preparación y sus usos
US11304902B2 (en) 2014-11-25 2022-04-19 Curadigm Sas Pharmaceutical compositions, preparation and uses thereof
EA201791138A1 (ru) 2014-11-25 2017-09-29 Нанобиотикс Фармацевтическая композиция, ее приготовление и применения
WO2016112314A1 (en) * 2015-01-08 2016-07-14 Purdue Research Foundation Non-toxic formulations of radio-luminescent nanoparticles for use as cancer radio-sensitizing agents
CN107708668A (zh) * 2015-05-28 2018-02-16 纳米生物技术公司 用作治疗性疫苗的纳米粒子
US11389536B2 (en) 2015-07-17 2022-07-19 BioCurity Pharmaceuticals Inc. Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent
CN109010828B (zh) * 2018-10-12 2020-10-20 中国科学院高能物理研究所 一种二硫化钼/二氧化铪的复合纳米材料、其制备方法及用途
CN109616308B (zh) * 2018-11-07 2020-09-04 湖北第二师范学院 一种球形纳米氧化铱dna提取磁性粉末及其生产方法
CN109771645B (zh) * 2019-03-07 2021-08-24 广西师范大学 一种二氧化钌复合卵清蛋白纳米材料的制备及其应用
KR20230038659A (ko) * 2020-05-26 2023-03-21 나노비오띡스 나노 입자, 전리 방사선 및 그의 혁신적인 치료용 조합
AU2021374754A1 (en) * 2020-11-05 2023-06-22 Nanobiotix Compositions of nanoparticles for treatment of cancer
CN116615269A (zh) * 2020-12-01 2023-08-18 纳米生物技术公司 作为辐射增强剂的多孔、高z和无碳颗粒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6287526A (ja) * 1985-10-11 1987-04-22 Akira Fujishima 抗腫瘍剤
WO2000006244A2 (en) 1998-07-30 2000-02-10 Hainfeld James F Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy
EP1696957A2 (en) 2003-12-17 2006-09-06 Philips Intellectual Property & Standards GmbH Radiation therapy and medical imaging using uv emitting nanoparticles
FR2869803B1 (fr) 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
US20070092927A1 (en) * 2005-06-13 2007-04-26 University Of Dayton Photocatalytic particles with directed and controlled redox activity
JP2007075696A (ja) * 2005-09-13 2007-03-29 Mitsubishi Materials Corp 多孔質光触媒膜
BRPI0713940A2 (pt) * 2006-07-10 2012-12-04 Konink Philips Eletronics N V nanopartìcula de núcleo e casca, e , uso e processo para fabricação da mesma
EP1920784A1 (en) * 2006-11-13 2008-05-14 Koninklijke Philips Electronics N.V. Radiation sensitizers in ionizing radiation therapy and imaging

Also Published As

Publication number Publication date
LT3150227T (lt) 2018-12-10
PT2300054T (pt) 2016-11-11
HRP20181993T1 (hr) 2019-01-25
IL209625A0 (en) 2011-02-28
KR101639281B1 (ko) 2016-07-13
WO2009147214A3 (en) 2010-02-25
DK3150227T3 (en) 2019-01-14
ES2602048T3 (es) 2017-02-17
TR201819077T4 (tr) 2019-01-21
PL3150227T3 (pl) 2019-05-31
HRP20161465T1 (hr) 2017-01-27
HRP20161465T8 (hr) 2017-04-21
BRPI0913410B1 (pt) 2021-09-21
SI2300054T1 (sl) 2017-02-28
CN102056628A (zh) 2011-05-11
JP2011524866A (ja) 2011-09-08
WO2009147214A2 (en) 2009-12-10
LT2300054T (lt) 2016-12-27
US20110213192A1 (en) 2011-09-01
US8845507B2 (en) 2014-09-30
MX2010013322A (es) 2011-01-21
JP5734181B2 (ja) 2015-06-17
EP2300054B1 (en) 2016-09-07
DK2300054T3 (en) 2016-12-05
CA2727576C (en) 2016-08-16
EP3461502A1 (en) 2019-04-03
PL2300054T3 (pl) 2017-04-28
CA2727576A1 (en) 2009-12-10
CN102056628B (zh) 2013-07-10
KR20110028616A (ko) 2011-03-21
IL209625A (en) 2015-11-30
HUE030669T2 (en) 2017-05-29
EP3150227A1 (en) 2017-04-05
ZA201100082B (en) 2011-10-26
AU2009254550B2 (en) 2013-10-24
HUE040247T2 (hu) 2019-02-28
EA023012B1 (ru) 2016-04-29
EA201071429A1 (ru) 2011-06-30
EP2300054A2 (en) 2011-03-30
AU2009254550A1 (en) 2009-12-10
CY1121078T1 (el) 2019-12-11
EP2130553A1 (en) 2009-12-09
EP3150227B1 (en) 2018-10-31
CY1118217T1 (el) 2017-06-28
SG10201405288WA (en) 2014-10-30
MA32453B1 (fr) 2011-07-03
NZ589888A (en) 2012-06-29
PT3150227T (pt) 2018-12-24
ES2702249T3 (es) 2019-02-28
BRPI0913410A2 (pt) 2015-11-24

Similar Documents

Publication Publication Date Title
HRP20181993T1 (hr) Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo
ZA201008392B (en) Treatment of pluripotent cells
EP2350770A4 (en) PROCESS FOR CONSCIOUS PERFORMANCE MANAGEMENT
EP2349918A4 (en) STABLE NANOPARTICLES AND METHODS OF PRODUCING AND USING THESE PARTICLES
SG10201401643PA (en) Methods for assessing cytotoxicity of single cells
EP2381936A4 (en) PATHS FOR GENERATING HAIR CELLS
EP2391579A4 (en) COMPOSITIONS OF SURFACE-MODIFIED NANOPARTICLES
EP2379458A4 (en) SELENIZATION OF A LAYER OF PRECURSORS CONTAINING NANOPARTICLES OF HIDES2
EP2460215A4 (en) THREE-DIMENSIONAL BATTERY ARCHITECTURES AND MANUFACTURING METHOD THEREFOR
EP2461953A4 (en) USE OF NANOPARTICLES IN COMPOSITE FIBERS
EP2393930A4 (en) CELLULAR LINES EXPRESSING CFTR AND METHODS OF USE THEREOF
IL218964A0 (en) Phototriggered nanoparticles for cell and tissue targeting
GB0808965D0 (en) Equipment to stimulate photosensitized cells
IL211567A0 (en) Use of stem cells to prevent neuronal dieback
IL216842A (en) Methods for producing hybrid / chimeric cells and their uses
GB0912103D0 (en) Energy consumption monitor
GB0915732D0 (en) Improvements in or relating to exfoliation
GB0800165D0 (en) Combined hydrogen and power production
GB0910401D0 (en) Production of nanoparticles
GB201015579D0 (en) Provision of electrical energy
HK1157387A1 (en) Use of hsa-producing cells
EP2318570A4 (en) ELECTROLYTIC CELL AND RELATED METHODS FOR THE PRODUCTION AND USE THEREOF
TWM370966U (en) Structure of travel backpack
TWM371297U (en) Improved structure of power lock
TWM374201U (en) Improved structure of power connector